# Tc99m Sestamibi Molecular Breast Imaging

> **NCT02324387** · NA · ACTIVE_NOT_RECRUITING · sponsor: **M.D. Anderson Cancer Center** · enrollment: 96 (actual)

## Conditions studied

- Breast Cancer

## Interventions

- **PROCEDURE:** Molecular Breast Imaging (MBI)
- **DRUG:** Tc99m sestamibi

## Key facts

- **NCT ID:** NCT02324387
- **Lead sponsor:** M.D. Anderson Cancer Center
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2015-06-15
- **Primary completion:** 2028-03-31
- **Final completion:** 2028-03-31
- **Target enrollment:** 96 (ACTUAL)
- **Last updated:** 2026-03-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02324387

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02324387, "Tc99m Sestamibi Molecular Breast Imaging". Retrieved via AI Analytics 2026-08-02 from https://api.ai-analytics.org/clinical/NCT02324387. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*